The global market for Alzheimer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Alzheimer’s is a neurodegenerative progressive disease. Alzheimer"s disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer"s disease is the cause of dementia. Many researchers consider anrease in the level of protein amyloid in the brain is one of the causes of Alzheimer disease. Older age is the prominent cause of Alzheimer"swhereas there are also some genetic and some other causes of Alzheimer diseases. The exact cause of Alzheimer’s disease is still unknown.

This report aims to provide a comprehensive presentation of the global market for Alzheimer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer.

The Alzheimer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alzheimer market comprehensively. Regional market sizes, concerning products by Drug Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alzheimer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Drug Type, by Application, and by regions.

Market Segmentation

Scope of Alzheimer Market Report

Report Metric	Details
Report Name	Alzheimer Market
Segment by Drug Type	Cholinesterase inhibitors Pipeline Drugs NMDA receptor antagonist
Segment by Application	Hospital Pharmacy Retail Pharmacy Online Sales
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Drug Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Drug Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Alzheimer Market report?

Ans: The main players in the Alzheimer Market are Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck

What are the Application segmentation covered in the Alzheimer Market report?

Ans: The Applications covered in the Alzheimer Market report are Hospital Pharmacy, Retail Pharmacy, Online Sales

What are the Type segmentation covered in the Alzheimer Market report?

Ans: The Types covered in the Alzheimer Market report are Cholinesterase inhibitors, Pipeline Drugs, NMDA receptor antagonist

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Drug Type

1.2.1 Global Alzheimer Market Size Growth Rate by Drug Type: 2020 VS 2024 VS 2031

1.2.2 Cholinesterase inhibitors

1.2.3 Pipeline Drugs

1.2.4 NMDA receptor antagonist

1.3 Market by Application

1.3.1 Global Alzheimer Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Sales

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Alzheimer Market Perspective (2020-2031)

2.2 Global Alzheimer Growth Trends by Region

2.2.1 Global Alzheimer Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Alzheimer Historic Market Size by Region (2020-2025)

2.2.3 Alzheimer Forecasted Market Size by Region (2026-2031)

2.3 Alzheimer Market Dynamics

2.3.1 Alzheimer Industry Trends

2.3.2 Alzheimer Market Drivers

2.3.3 Alzheimer Market Challenges

2.3.4 Alzheimer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Alzheimer Players by Revenue

3.1.1 Global Top Alzheimer Players by Revenue (2020-2025)

3.1.2 Global Alzheimer Revenue Market Share by Players (2020-2025)

3.2 Global Alzheimer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Alzheimer Revenue

3.4 Global Alzheimer Market Concentration Ratio

3.4.1 Global Alzheimer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alzheimer Revenue in 2024

3.5 Global Key Players of Alzheimer Head office and Area Served

3.6 Global Key Players of Alzheimer, Product and Application

3.7 Global Key Players of Alzheimer, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Alzheimer Breakdown Data by Drug Type

4.1 Global Alzheimer Historic Market Size by Drug Type (2020-2025)

4.2 Global Alzheimer Forecasted Market Size by Drug Type (2026-2031)

5 Alzheimer Breakdown Data by Application

5.1 Global Alzheimer Historic Market Size by Application (2020-2025)

5.2 Global Alzheimer Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Alzheimer Market Size (2020-2031)

6.2 North America Alzheimer Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Alzheimer Market Size by Country (2020-2025)

6.4 North America Alzheimer Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Alzheimer Market Size (2020-2031)

7.2 Europe Alzheimer Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Alzheimer Market Size by Country (2020-2025)

7.4 Europe Alzheimer Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Alzheimer Market Size (2020-2031)

8.2 Asia-Pacific Alzheimer Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Alzheimer Market Size by Region (2020-2025)

8.4 Asia-Pacific Alzheimer Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Alzheimer Market Size (2020-2031)

9.2 Latin America Alzheimer Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Alzheimer Market Size by Country (2020-2025)

9.4 Latin America Alzheimer Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Alzheimer Market Size (2020-2031)

10.2 Middle East & Africa Alzheimer Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Alzheimer Market Size by Country (2020-2025)

10.4 Middle East & Africa Alzheimer Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Allergan

11.1.1 Allergan Company Details

11.1.2 Allergan Business Overview

11.1.3 Allergan Alzheimer Introduction

11.1.4 Allergan Revenue in Alzheimer Business (2020-2025)

11.1.5 Allergan Recent Development

11.2 Eisai

11.2.1 Eisai Company Details

11.2.2 Eisai Business Overview

11.2.3 Eisai Alzheimer Introduction

11.2.4 Eisai Revenue in Alzheimer Business (2020-2025)

11.2.5 Eisai Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Alzheimer Introduction

11.3.4 Novartis Revenue in Alzheimer Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Daiichi Sankyo

11.4.1 Daiichi Sankyo Company Details

11.4.2 Daiichi Sankyo Business Overview

11.4.3 Daiichi Sankyo Alzheimer Introduction

11.4.4 Daiichi Sankyo Revenue in Alzheimer Business (2020-2025)

11.4.5 Daiichi Sankyo Recent Development

11.5 Merz Pharma

11.5.1 Merz Pharma Company Details

11.5.2 Merz Pharma Business Overview

11.5.3 Merz Pharma Alzheimer Introduction

11.5.4 Merz Pharma Revenue in Alzheimer Business (2020-2025)

11.5.5 Merz Pharma Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Alzheimer Introduction

11.6.4 Pfizer Revenue in Alzheimer Business (2020-2025)

11.6.5 Pfizer Recent Development

11.7 Johnson & Johnson

11.7.1 Johnson & Johnson Company Details

11.7.2 Johnson & Johnson Business Overview

11.7.3 Johnson & Johnson Alzheimer Introduction

11.7.4 Johnson & Johnson Revenue in Alzheimer Business (2020-2025)

11.7.5 Johnson & Johnson Recent Development

11.8 Lundbeck

11.8.1 Lundbeck Company Details

11.8.2 Lundbeck Business Overview

11.8.3 Lundbeck Alzheimer Introduction

11.8.4 Lundbeck Revenue in Alzheimer Business (2020-2025)

11.8.5 Lundbeck Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Alzheimer Market Size Growth Rate by Drug Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cholinesterase inhibitors

Table 3. Key Players of Pipeline Drugs

Table 4. Key Players of NMDA receptor antagonist

Table 5. Global Alzheimer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Alzheimer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Alzheimer Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Alzheimer Market Share by Region (2020-2025)

Table 9. Global Alzheimer Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Alzheimer Market Share by Region (2026-2031)

Table 11. Alzheimer Market Trends

Table 12. Alzheimer Market Drivers

Table 13. Alzheimer Market Challenges

Table 14. Alzheimer Market Restraints

Table 15. Global Alzheimer Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Alzheimer Market Share by Players (2020-2025)

Table 17. Global Top Alzheimer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer as of 2024)

Table 18. Ranking of Global Top Alzheimer Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Alzheimer Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Alzheimer, Headquarters and Area Served

Table 21. Global Key Players of Alzheimer, Product and Application

Table 22. Global Key Players of Alzheimer, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Alzheimer Market Size by Drug Type (2020-2025) & (US$ Million)

Table 25. Global Alzheimer Revenue Market Share by Drug Type (2020-2025)

Table 26. Global Alzheimer Forecasted Market Size by Drug Type (2026-2031) & (US$ Million)

Table 27. Global Alzheimer Revenue Market Share by Drug Type (2026-2031)

Table 28. Global Alzheimer Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Alzheimer Revenue Market Share by Application (2020-2025)

Table 30. Global Alzheimer Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Alzheimer Revenue Market Share by Application (2026-2031)

Table 32. North America Alzheimer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Alzheimer Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Alzheimer Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Alzheimer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Alzheimer Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Alzheimer Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Alzheimer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Alzheimer Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Alzheimer Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Alzheimer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Alzheimer Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Alzheimer Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Alzheimer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Alzheimer Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Alzheimer Market Size by Country (2026-2031) & (US$ Million)

Table 47. Allergan Company Details

Table 48. Allergan Business Overview

Table 49. Allergan Alzheimer Product

Table 50. Allergan Revenue in Alzheimer Business (2020-2025) & (US$ Million)

Table 51. Allergan Recent Development

Table 52. Eisai Company Details

Table 53. Eisai Business Overview

Table 54. Eisai Alzheimer Product

Table 55. Eisai Revenue in Alzheimer Business (2020-2025) & (US$ Million)

Table 56. Eisai Recent Development

Table 57. Novartis Company Details

Table 58. Novartis Business Overview

Table 59. Novartis Alzheimer Product

Table 60. Novartis Revenue in Alzheimer Business (2020-2025) & (US$ Million)

Table 61. Novartis Recent Development

Table 62. Daiichi Sankyo Company Details

Table 63. Daiichi Sankyo Business Overview

Table 64. Daiichi Sankyo Alzheimer Product

Table 65. Daiichi Sankyo Revenue in Alzheimer Business (2020-2025) & (US$ Million)

Table 66. Daiichi Sankyo Recent Development

Table 67. Merz Pharma Company Details

Table 68. Merz Pharma Business Overview

Table 69. Merz Pharma Alzheimer Product

Table 70. Merz Pharma Revenue in Alzheimer Business (2020-2025) & (US$ Million)

Table 71. Merz Pharma Recent Development

Table 72. Pfizer Company Details

Table 73. Pfizer Business Overview

Table 74. Pfizer Alzheimer Product

Table 75. Pfizer Revenue in Alzheimer Business (2020-2025) & (US$ Million)

Table 76. Pfizer Recent Development

Table 77. Johnson & Johnson Company Details

Table 78. Johnson & Johnson Business Overview

Table 79. Johnson & Johnson Alzheimer Product

Table 80. Johnson & Johnson Revenue in Alzheimer Business (2020-2025) & (US$ Million)

Table 81. Johnson & Johnson Recent Development

Table 82. Lundbeck Company Details

Table 83. Lundbeck Business Overview

Table 84. Lundbeck Alzheimer Product

Table 85. Lundbeck Revenue in Alzheimer Business (2020-2025) & (US$ Million)

Table 86. Lundbeck Recent Development

Table 87. Research Programs/Design for This Report

Table 88. Key Data Information from Secondary Sources

Table 89. Key Data Information from Primary Sources

Table 90. Authors List of This Report

List of Figures

Figure 1. Alzheimer Picture

Figure 2. Global Alzheimer Market Size Comparison by Drug Type (2020-2031) & (US$ Million)

Figure 3. Global Alzheimer Market Share by Drug Type: 2024 VS 2031

Figure 4. Cholinesterase inhibitors Features

Figure 5. Pipeline Drugs Features

Figure 6. NMDA receptor antagonist Features

Figure 7. Global Alzheimer Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Alzheimer Market Share by Application: 2024 VS 2031

Figure 9. Hospital Pharmacy Case Studies

Figure 10. Retail Pharmacy Case Studies

Figure 11. Online Sales Case Studies

Figure 12. Alzheimer Report Years Considered

Figure 13. Global Alzheimer Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Alzheimer Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Alzheimer Market Share by Region: 2024 VS 2031

Figure 16. Global Alzheimer Market Share by Players in 2024

Figure 17. Global Top Alzheimer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Alzheimer Revenue in 2024

Figure 19. North America Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Alzheimer Market Share by Country (2020-2031)

Figure 21. United States Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Alzheimer Market Share by Country (2020-2031)

Figure 25. Germany Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Alzheimer Market Share by Region (2020-2031)

Figure 33. China Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Alzheimer Market Share by Country (2020-2031)

Figure 41. Mexico Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Alzheimer Market Share by Country (2020-2031)

Figure 45. Turkey Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Alzheimer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Allergan Revenue Growth Rate in Alzheimer Business (2020-2025)

Figure 49. Eisai Revenue Growth Rate in Alzheimer Business (2020-2025)

Figure 50. Novartis Revenue Growth Rate in Alzheimer Business (2020-2025)

Figure 51. Daiichi Sankyo Revenue Growth Rate in Alzheimer Business (2020-2025)

Figure 52. Merz Pharma Revenue Growth Rate in Alzheimer Business (2020-2025)

Figure 53. Pfizer Revenue Growth Rate in Alzheimer Business (2020-2025)

Figure 54. Johnson & Johnson Revenue Growth Rate in Alzheimer Business (2020-2025)

Figure 55. Lundbeck Revenue Growth Rate in Alzheimer Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions